SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.180-0.8%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Karin who wrote (1256)11/6/1998 10:21:00 PM
From: RockyBalboa  Read Replies (2) of 3576
 
No, not earnings. Whar matters is the economic outlook within the next few years.

AOL, YHOO, even AMZN are differen stories to tell. YHOO posts (small) profits and has a product we all use today. YHOO has reached a step GERN could reach in 5 years.

At least if there are no earnings, there are revenues or - numbers, like page count, which are used to estimate forward revenues. Clear. There are ways to value Yahoo, and the market seems to adopt and support the skyhigh yhoo valuation. I know only few guys which shorted yhoo - with little chance of success.

That makes the difference.

Geron is an option with an indefinite expiry date, like many company shares are options, they can get in the money or they expire worthless. Problem is that the Geron underlying is not visible yet.

C.

As always, if there is a greater fool, sell him stocks as long as u can
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext